Instem to Present at Society of Toxicologic Pathology Annual Symposium, Washington DC
Instem presenting “Use of Legacy Data to Assess Species Concordance for Liver Injury”
CONSHOHOCKEN, PA – (Business Wire) - June 19, 2014 - -Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that Stephanie Berry, Head of Safety Information Management – Data Integration & Bioinformatics, Instem, will be presenting at the 33rd Annual Society of Toxicologic Pathology (STP) Symposium in Washington, DC.
The poster presentation, “Use of Legacy Data to Assess Species Concordance for Liver Injury”, will discuss how Instem's Safety Intelligence Program (SIP) Tox/Path reference knowledgebase can be used to demonstrate how legacy data from different sources can determine drug effects from early testing through to market, and provide insight into the translational utility of non-human models.
Ms. Berry said, “This research shows how Instem’s tools can be used to assess the concordance of drug effects in pre-clinical species and man. Our SIP knowledgebase enables a rapid review of what is known in the public domain about drug safety effects, and provides this summary in a format that can be readily analyzed. Instem’s OmniViz analytical platform then allows us to look deeper into this data, to identify key drug classes and pathological effects that correlate well, or poorly, between different species.”
“Use of Legacy Data to Assess Species Concordance for Liver Injury” will be on display at STP Exhibit Hall C from 3pm Sunday June 22nd until 11:30am Wednesday June 25th.
Delegates can see the SIP Tox/Path Knowledgebase and OmniViz solutions in action at Instem’s Trade Show Booth #300. At the booth, Instem will also be showcasing their market-leading Provantis® Pathology software solution for the collection, processing and reporting of data for gross and histopathology, as well as the submit™ suite of solutions for creating, managing and reviewing SEND data sets.
The STP is a non-profit association of pathologists and other scientists whose principal aim is the advancement of pathology as it pertains to changes elicited by pharmacological, chemical, or environmental agents, and factors that modify these responses. STP members are dedicated to the integration of toxicologic pathology into hazard identification, risk assessment, and risk communication regarding human and animal exposure to potentially toxic substances.
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600